Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$86.23 - $125.19 $1.4 Million - $2.04 Million
-16,262 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$79.17 - $111.47 $1.29 Million - $1.81 Million
16,262 New
16,262 $1.46 Million
Q2 2020

Aug 10, 2020

SELL
$54.33 - $89.52 $476,745 - $785,538
-8,775 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$49.34 - $68.76 $403,354 - $562,113
8,175 Added 1362.5%
8,775 $508,000
Q4 2019

Feb 04, 2020

BUY
$51.21 - $59.06 $30,726 - $35,436
600 New
600 $32,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $289M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.